US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,812.30

-12.6875-0.70%

Number of Gainers:9

Number of Losers:10

Number of Flat:- -

PE:- -

High:1,831.56

Open:1,825.61

Low:1,808.53

Close:1,824.99

Volume:30.37M

Turnover:2.69B

Market Cap:1.47T

Float Cap:1.44T

Loading ...

Pfizer Says Tilrekimig Hits Phase 2 Atopic Dermatitis Endpoint with 62.5% EASI-75 at Week 16

Pfizer - no Serious Adverse Events Related to Tilrekimig in Phase 2 Study

THOMSON REUTERS

Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study

THOMSON REUTERS

Pfizer - Tilrekimig Well-Tolerated with Teae Rates Comparable to Placebo

THOMSON REUTERS

Pfizer - 62.5% of Patients on Tilrekimig 450 Mg Q2w Achieve Easi-75 vs 19.9% Placebo

THOMSON REUTERS

Pfizer - Phase 2 Study Meets Primary Endpoint with Significant Easi-75 Improvement at Week 16

THOMSON REUTERS

Alpha Pro Tech Director Donna Millar Disposes of 15,000 Common Shares Worth $75,600

Agilent Technologies Inc. Stock Underperforms Wednesday When Compared to Competitors

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

BioNTech CEO Uğur Şahin Disposes of $6.48 Million in Common Shares

Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline

Corvus announces initiation of Phase 1b clinical trial of soquelitinib

Corvus Starts Phase 1b Trial of Soquelitinib in Hidradenitis Suppurativa Patients

Corvus Pharmaceuticals, - Primary Endpoint is Safety and Tolerability; Key Efficacy Endpoint is Hiscr 50/75 at Week 12

THOMSON REUTERS

Corvus Pharmaceuticals Announces Initiation of Phase 1B Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa

THOMSON REUTERS

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Gilead put volume heavy and directionally bearish

BioNTech Steps Deeper Into Lung Cancer With New Dareon-Rosetta35 Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK4568/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1812.298,"timestamp":1790956347606,"preClose":1824.9855,"halted":0,"volume":30370026,"delay":0,"changeRate":-0.006952,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-12.6875,"latestTime":"10-02 11:52:27 EDT","open":1825.6097,"high":1831.557,"low":1808.5321,"amount":2693581933.275984,"amplitude":0.012616,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.847322,"peRate":47.020292,"turnoverRate":0.002189,"increases":9,"decrements":10,"flats":0,"marketCap":1474121082827,"floatMarketCap":1439028499741},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1831.557,"amplitude":0.012616,"preClose":1824.9855,"low":1808.5321,"pbRate":"4.847322","latestPrice":1812.3027,"volume":30369825,"delay":0,"open":1825.6097,"prevYearClose":1637.1339,"prevWeekClose":1903.4879,"prevMonthClose":1862.664,"prevQuarterClose":1862.664,"fiveDayClose":1903.4879,"twentyDayClose":1915.5433,"sixtyDayClose":1751.8207,"secType":"PLATE","market":"US","turnoverRate":0.002189,"peRate":47.020292,"marketCap":1474121082827,"floatMarketCap":1439028499741,"timestamp":1790956347498,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":9,"down":10,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672375367","title":"Pfizer Says Tilrekimig Hits Phase 2 Atopic Dermatitis Endpoint with 62.5% EASI-75 at Week 16","url":"https://stock-news.laohu8.com/highlight/detail?id=2672375367","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672375367?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:31","pubTimestamp":1790836262,"startTime":"0","endTime":"0","summary":"Pfizer says tilrekimig hits Phase 2 atopic dermatitis endpoint with 62.5% EASI-75 at week 16Pfizer presented Phase 2 results for tilrekimig in moderate-to-severe atopic dermatitis at the EADV congress","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL9zmvR2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","BK4588","IE00BLSP4452.SGD","BK4534","BK4550","LU0122379950.USD","LU0456855351.SGD","IE000M9KFDE8.USD","BK4007","SG9999013999.USD","SG9999003800.SGD","SG9999011175.SGD","BK4581","LU1894683264.USD","LU0234572021.USD","LU0985481810.HKD","LU1066051498.USD","SG9999002232.USD","LU0225771236.USD","SGXZ57979304.SGD","BK4599","SG9999002224.SGD","LU0058720904.USD","BK4585","LU1894683348.USD","LU1057294990.SGD","LU1066053197.SGD","LU0868494617.USD","LU0321505439.SGD","LU1883839398.USD","BK4568","OZEM","LU0306806265.USD","IE00BLSP4239.USD","SG9999001176.USD","LU2596442595.SGD","IE0002270589.USD","IE00BBT3K403.USD","LU0306807586.USD","IE00B19Z3581.USD","BK4533","LU0289739699.SGD","LU0321505868.SGD","PFE","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0225284248.USD","SG9999001176.SGD","LU0170899867.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672573738","title":"Pfizer - no Serious Adverse Events Related to Tilrekimig in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672573738","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672573738?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","LU0122379950.USD","LU0170899867.USD","LU2596442595.SGD","LU1894683264.USD","LU0289739699.SGD","LU1066051498.USD","LU1066053197.SGD","LU0306806265.USD","LU0306807586.USD","LU0868494617.USD","SG9999011175.SGD","BK4592","IE00B19Z3581.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU0456855351.SGD","LU0225771236.USD","IE00BLSP4239.USD","PFE","LU0234572021.USD","IE00BBT3K403.USD","LU1057294990.SGD","BK4585","IE00B3T34201.USD","BK4007","LU0321505868.SGD","BK4534","SG9999003800.SGD","LU0058720904.USD","SG9999002224.SGD","SGXZ57979304.SGD","LU0985481810.HKD","OZEM","BK4599","BK4588","IE00B19Z3B42.SGD","SG9999001176.USD","BK4568","IE00BLSP4452.SGD","LU0321505439.SGD","SG9999001176.SGD","BK4550","LU0225284248.USD","BK4581","LU1023059063.AUD","SG9999013999.USD","SG9999002232.USD","LU1883839398.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672382737","title":"Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672382737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672382737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","LU0122379950.USD","LU0170899867.USD","LU2596442595.SGD","LU1894683264.USD","LU0289739699.SGD","LU1066051498.USD","LU1066053197.SGD","LU0306806265.USD","LU0306807586.USD","LU0868494617.USD","SG9999011175.SGD","BK4592","IE00B19Z3581.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU0456855351.SGD","LU0225771236.USD","IE00BLSP4239.USD","PFE","LU0234572021.USD","IE00BBT3K403.USD","LU1057294990.SGD","BK4585","IE00B3T34201.USD","BK4007","LU0321505868.SGD","BK4534","SG9999003800.SGD","LU0058720904.USD","SG9999002224.SGD","SGXZ57979304.SGD","LU0985481810.HKD","OZEM","BK4599","BK4588","IE00B19Z3B42.SGD","SG9999001176.USD","BK4568","IE00BLSP4452.SGD","LU0321505439.SGD","SG9999001176.SGD","BK4550","LU0225284248.USD","BK4581","LU1023059063.AUD","SG9999013999.USD","SG9999002232.USD","LU1883839398.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672338737","title":"Pfizer - Tilrekimig Well-Tolerated with Teae Rates Comparable to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672338737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672338737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0170899867.USD","LU1883839398.USD","LU1894683348.USD","BK4585","IE000M9KFDE8.USD","BK4599","LU0321505868.SGD","LU0225771236.USD","LU0306807586.USD","SG9999011175.SGD","OZEM","IE00BLSP4452.SGD","SG9999002224.SGD","BK4581","LU1894683264.USD","LU0985481810.HKD","LU0306806265.USD","IE00B19Z3581.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","IE00B3T34201.USD","BK4550","LU0234572021.USD","IE0002270589.USD","LU0058720904.USD","LU0456855351.SGD","SGXZ57979304.SGD","BK4534","BK4588","PFE","LU0868494617.USD","LU1023059063.AUD","LU0122379950.USD","SG9999002232.USD","BK4592","BK4568","LU0289739699.SGD","BK4533","BK4007","LU0225284248.USD","LU1066053197.SGD","LU1057294990.SGD","LU1066051498.USD","SG9999013999.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999001176.USD","LU0321505439.SGD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672334737","title":"Pfizer - 62.5% of Patients on Tilrekimig 450 Mg Q2w Achieve Easi-75 vs 19.9% Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672334737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672334737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4592","BK4588","IE00BLSP4452.SGD","BK4534","BK4550","LU0122379950.USD","LU0456855351.SGD","IE000M9KFDE8.USD","BK4007","SG9999013999.USD","SG9999003800.SGD","SG9999011175.SGD","BK4581","LU1894683264.USD","LU0234572021.USD","LU0985481810.HKD","LU1066051498.USD","SG9999002232.USD","LU0225771236.USD","SGXZ57979304.SGD","BK4599","SG9999002224.SGD","LU0058720904.USD","BK4585","LU1894683348.USD","LU1057294990.SGD","LU1066053197.SGD","LU0868494617.USD","LU0321505439.SGD","LU1883839398.USD","BK4568","OZEM","LU0306806265.USD","IE00BLSP4239.USD","SG9999001176.USD","LU2596442595.SGD","IE0002270589.USD","IE00BBT3K403.USD","LU0306807586.USD","IE00B19Z3581.USD","BK4533","LU0289739699.SGD","LU0321505868.SGD","PFE","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0225284248.USD","SG9999001176.SGD","LU0170899867.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672273733","title":"Pfizer - Phase 2 Study Meets Primary Endpoint with Significant Easi-75 Improvement at Week 16","url":"https://stock-news.laohu8.com/highlight/detail?id=2672273733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672273733?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001176.USD","BK4599","IE00B3T34201.USD","LU0170899867.USD","BK4534","SG9999011175.SGD","LU0289739699.SGD","SG9999002224.SGD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","BK4568","LU0122379950.USD","LU2596442595.SGD","BK4592","IE00BBT3K403.USD","LU0868494617.USD","LU1894683348.USD","OZEM","SG9999002232.USD","BK4550","SG9999003800.SGD","BK4581","LU0225771236.USD","LU0985481810.HKD","LU0234572021.USD","LU1894683264.USD","PFE","BK4533","SG9999001176.SGD","LU1883839398.USD","BK4585","SGXZ57979304.SGD","BK4007","LU0306806265.USD","LU1066053197.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU0321505868.SGD","BK4588","LU0321505439.SGD","LU0058720904.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU1066051498.USD","SG9999013999.USD","LU0306807586.USD","LU1023059063.AUD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787788","title":"Alpha Pro Tech Director Donna Millar Disposes of 15,000 Common Shares Worth $75,600","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787788","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787788?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:15","pubTimestamp":1790802937,"startTime":"0","endTime":"0","summary":"Alpha Pro Tech director Donna Millar disposes of 15,000 common shares worth $75,600Alpha Pro Tech director Donna Millar reported net sales of 15,000 common shares on Sept. 28, 2026 at USD 5.04.Holding","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDLbKBrMv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alpha Pro Tech Director Donna Millar Disposes of 15,000 Common Shares Worth $75,600","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4086","APT","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787680","title":"Agilent Technologies Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787680?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:51","pubTimestamp":1790801460,"startTime":"0","endTime":"0","summary":"DJ Agilent Technologies Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Agilent Technologies Inc.  slipped 1.55% to $172.31 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's second consecutive day of losses.Agilent Technologies Inc. closed 2.68% short of its 52-week high of $177.05, which the company achieved on September 29th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Thermo Fisher Scientific Inc.  fell 0.67% to $675.05, Danaher Corp.  fell 1.84% to $221.55, and Abbott Laboratories  fell 2.10% to $98.83.Trading volume  eclipsed its 50-day average volume of 2.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1803068623.USD","IE00B4R5TH58.HKD","LU1923622291.USD","LU2764263203.CNY","LU0048573561.USD","HRTS","FMED","LU2125909759.SGD","LU2125909916.SGD","TMO","BK4592","LU1720051017.SGD","IE00BJJMRZ35.SGD","LU2764262908.HKD","LU2023250504.SGD","IE0002141913.USD","LU1721429741.USD","BK4534","LU0957791311.USD","LU1165135440.EUR","BK4585","LU1983299246.USD","IE00BQXX3F31.USD","LU0266013472.USD","LU0708994859.HKD","LU1057294990.SGD","IE00BQXX3D17.EUR","LU0347712357.USD","LU2063271972.USD","PJP","LU1989771016.USD","A","IE00BZ1G4Q59.USD","TMED","LU0058720904.USD","IE00B19Z8W00.USD","LU0345770308.USD","DHR","GNMX","LU1854104046.USD","LU0820561818.USD","IHI","LU1721428933.USD","LU0312595415.SGD","LU1721429402.USD","ABT","LU1551013342.USD","LU1804176565.USD","LU0061474960.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782095","title":"Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782095","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782095?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:36","pubTimestamp":1790800560,"startTime":"0","endTime":"0","summary":"DJ Abbott Laboratories Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Abbott Laboratories  slid 2.10% to $98.83 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's third consecutive day of losses.Abbott Laboratories closed 27.04% short of its 52-week high of $135.45, which the company reached on October 1st.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.06% to $264.74, Pfizer Inc.  fell 0.70% to $28.52, and Merck & Co. Inc.  fell 2.66% to $145.31.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","LU1585245621.USD","LU1069347547.HKD","LU1057294990.SGD","LU1261432733.SGD","LU1699723380.USD","LU2211815571.USD","LU1093756168.USD","LU0266013472.USD","LU0456855351.SGD","IE0009355771.USD","LU2125154778.USD","LU1934455277.USD","LU2213496289.HKD","IE00BBT3K403.USD","BK4504","LU0795875169.SGD","IE000M9KFDE8.USD","LU1244550577.SGD","BK4082","PPH","LU2430703178.SGD","LU0289739343.SGD","LU0162691827.USD","LU0238689110.USD","LU2125154935.USD","LU0225284248.USD","LU1201861249.SGD","BK4532","MRK","LU1551013425.SGD","IE00BVYPNV92.GBP","LU1116320901.HKD","IE00BN8TJ469.HKD","LU0321505439.SGD","LU2756315664.SGD","IE00BJJMRZ35.SGD","LU0648001328.SGD","LU0069063385.USD","LU0057025933.USD","MEDX","IE0000B7K699.USD","IE00BLSP4452.SGD","LU0861579265.USD","LU0265550359.USD","OZEM","IE00BKVL7J92.USD","LU1023059063.AUD","SG9999014559.SGD","LU0795875086.SGD","LU1732799900.SGD","LU1989771016.USD","LU0965509283.SGD","LU1983299246.USD","LU0170899867.USD","BK4599","LU0053666078.USD","LU1989763690.USD","LU0949170772.SGD","SGXZ57979304.SGD","SG9999003800.SGD","LU1162221912.USD","BK4588","LU1228905037.USD","LU0823416689.USD","LU0820561818.USD","LU1228905540.USD","LU0640476718.USD","VHT","IE00B1BXHZ80.USD","LU1989772840.SGD","LU1196500208.SGD","LU0130102774.USD","LU0070217475.USD","SG9999004303.SGD","LU0820561909.HKD","LU0868494617.USD","LU2491050071.SGD","LU2491049909.HKD","LU0072461881.USD","LU2491050154.USD","JNJ","LU1629891620.HKD","BK4559","LU0320765646.SGD","LU1691799644.USD","LU0289961442.SGD","SG9999013999.USD","LU1043141123.HKD","LU1145028129.USD","LU0980610538.SGD","LU1037948897.HKD","LU2106854487.HKD","LU2403377893.USD","IE00B42XCP33.USD","LU1066051498.USD","IE000WAW04H5.SGD","LU0098860793.USD","LU2129689514.USD","IE0001KFT4U8.USD","LU2750360997.AUD","LU1035773651.USD","IE000F7OJYX1.SGD","LU0942090050.USD","BK4007","BK4568","LU2750360641.GBP","LU2357627491.SGD","RXL","SG9999002224.SGD","LU0225771236.USD","LU1221951046.USD","LU0210528500.USD","SG9999011175.SGD","LU1267930813.SGD","LU1670627923.USD","BK4566","BK4592","LU0124676726.USD","ABT","LU2471134796.USD","LU2361045086.USD","SGXZ80539844.SGD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","LU0868494708.USD","LU2324357040.USD","SGXZ23171101.USD","LU2347655156.SGD","LU0234572021.USD","LU0203345920.USD","LU0345769631.USD","LU1061106388.HKD","SG9999015358.SGD","SG9999001440.SGD","PJP","LU1721429741.USD","LU2360032135.SGD","LU1244550494.USD","LU0432979614.USD","LU0208291251.USD","LU0306807586.USD","LU1941712348.USD","FTXH","IE000SO60NU8.SGD","IE0002141913.USD","LU1121112475.USD","LU0472753341.HKD","IE00B2B36J28.USD","LU0689472784.USD","LU1093756325.SGD","LU2237957811.SGD","LU1059921491.USD","LU2023250330.USD","LU1914381329.SGD","BK4516","LU1551013342.USD","LU1074936037.SGD","LU0943347566.SGD","LU0882574055.USD","LU0234570918.USD","LU0553294199.USD","LU1043141396.HKD","SG9999014542.SGD","BK4550","LU0070302665.USD","LU1496350502.SGD","LU2505996681.GBP","LU0106261372.USD","LU2471134879.HKD","LU1674673691.USD","LU1934455863.HKD","BK4581","LU0661504455.SGD","LU0058720904.USD","BMED","IE0002270589.USD","HRTS","LU1923622614.USD","SG9999001176.USD","LU1778281490.HKD","XLV","SG9999001176.SGD","LU2129689431.USD","LU1221951129.SGD","LU1935042991.SGD","LU0738911758.USD","IE00B4R5TH58.HKD","LU0965509101.SGD","IHE","LU2023250504.SGD","LU2471134523.USD","LU0345769128.USD","LU0859254822.USD","LU1974910355.USD","LU2133065610.SGD","BK4533","IE00BZ1G4Q59.USD","GDOC","LU1894683348.USD","LU0787776722.HKD","LU1941712264.USD","LU1032466523.USD","LU2361044949.HKD","LU1721429402.USD","LU0211331839.USD","LU0210536198.USD","IE00B7SZLL34.SGD","IYH","LU0122379950.USD","LU0545039389.USD","LU1116320737.USD","LU1732800096.USD","IE00BJT1NW94.SGD","LU1066053197.SGD","IE0034235303.USD","LU2430703095.HKD","LU2430703251.USD","TRUH","IE000BZT7R73.USD","IE00B3T34201.USD","LU2592432038.USD","JDOC","BK4534","LU1989772923.USD","IE00B19Z3581.USD","LU2125909247.SGD","LU2461242641.AUD","LU0345770993.USD","LU0320765489.SGD","IE00BVYPNW00.USD","TMED","LU0511384066.AUD","LU2487616109.SGD","PAWZ","IE00B3PB1722.GBP","LU1066051225.USD","LU0130517989.USD","FHLC","LU2468319806.SGD","IXJ","LU0545562505.USD","IE000MB6IJN5.SGD","LU0345770308.USD","PFE","LU2112291526.USD","LU2125909593.SGD","LU1917777945.USD","LU2433249047.HKD","LU0994945656.USD","LU2471134952.CNY","LU0964807845.USD","IE00BFXG1179.USD","LU0289739699.SGD","LU1934455194.USD","LU1280957306.USD","LU0426417589.USD","LU0912757837.SGD","SG9999002232.USD","SGXZ41872573.SGD","LU1003077747.HKD","LU0306806265.USD","LU1883839398.USD","LU1674673428.USD","SG9999015341.SGD","LU0965509010.AUD","LU1989763427.SGD","LU2505996509.AUD","LU0792757196.USD","LU1430594728.SGD","LU2129689605.HKD","LU0985320562.USD","IE00BLSP4239.USD","LU0114720955.EUR","LU1032955483.USD","IE00BFTCPJ56.SGD","LU0889566641.SGD","LU1291159041.SGD","LU1718418525.SGD","LU0321505868.SGD","LU2361044865.SGD","LU0426412945.USD","LU0689626769.HKD","LU2602419157.SGD","LU0203347892.USD","LU1066051811.HKD","LU1244550221.USD","LU0985481810.HKD","LU1506573853.SGD","LU1894683264.USD","IE00BDGV0183.EUR","LU2756315318.SGD","LU2456880835.USD","SG9999014575.USD","LU0265550946.USD","LU1571399168.USD","BK4585","LU2596442595.SGD","IHI","SG9999014567.USD","LU0683600562.USD","LU2896262040.SGD","LU0477156953.USD","LU0006306889.USD","LU2236285917.USD","LU0466842654.USD","LU1670628061.USD","LU1037948541.HKD","LU2089984988.USD","IE00BSNM7G36.USD","LU2417539215.USD","LU0820562030.AUD","LU2237957902.USD","LU2023250843.SGD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672774782","title":"Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672774782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672774782?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:35","pubTimestamp":1790800500,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.47% to $149.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 5.24% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.06% to $264.74, Pfizer Inc.  fell 0.70% to $28.52, and Abbott Laboratories  fell 2.10% to $98.83.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","LU2089984988.USD","LU0859254822.USD","LU0114720955.EUR","LU1839511570.USD","SG9999015952.SGD","LU0882574055.USD","LU0122379950.USD","BK4139","LU1037948541.HKD","IE00B19Z3581.USD","LU0320765992.SGD","LU1674673428.USD","BIB","IE00B7SZLL34.SGD","LU0861579265.USD","LU1585245621.USD","LU2468319806.SGD","IBB","LU2324357040.USD","BK4588","LU0058720904.USD","LU0289739699.SGD","LU1023059063.AUD","LU1674673691.USD","LU1061106388.HKD","LU1571399168.USD","LU1066053197.SGD","GILD","BK4566","IE0002270589.USD","LU1057294990.SGD","LU2357627491.SGD","BBH","BK4550","BK4578","LU1430594728.SGD","LU0823416689.USD","LU2112291526.USD","BK4585","LU1934455194.USD","LU1037948897.HKD","BK4583","MEDI","LU1778281490.HKD","SG9999015945.SGD","SG9999015986.USD","LU0109394709.USD","LU0889565916.HKD","IE00BSNM7G36.USD","SG9999015978.USD","LU0965509010.AUD","TBXU","IE00B3T34201.USD","LU0965509101.SGD","LU1934455277.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0965508806.USD","BK4568","LU1066051498.USD","IBBQ","TMED","LU2087621335.USD","BK4532","LU0234570918.USD","BMED","IE00B19Z3B42.SGD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672278203","title":"Moderna Inc. Stock Sheds 5.4%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2672278203","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672278203?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:33","pubTimestamp":1790800380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 5.4% to $192.57 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,861.06 and the Dow Jones Industrial Average falling 0.9% to 50,906.05.Moderna Inc. closed 7.8% short of its 52-week high of $208.90, which the company reached on September 29th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $264.74, Pfizer Inc. fell 0.7% to $28.52, and Gilead Sciences Inc. fell 1.47% to $149.05.Trading volume totaled 20.1 million, compared to the 50-day average of 19.4 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IBB","WDNA","LU0109394709.USD","LU1778281490.HKD","BK4566","LU1934455863.HKD","LU0320765992.SGD","LU1934455194.USD","SG9999015952.SGD","BMED","LU1674673691.USD","IE00BSNM7G36.USD","LU1430594728.SGD","TBXU","LU1934455277.USD","MRNY","BK4550","IE00B19Z3B42.SGD","LU2357627491.SGD","MRNA","BK4534","IE0002270589.USD","BK4585","BK4139","LU1057294990.SGD","LU1066053197.SGD","BK4532","LGHT","LU1066051498.USD","BIB","LU2087621335.USD","IE00BZ1G4Q59.USD","MRNX","IDNA","TMED","LU0058720904.USD","LU1023059063.AUD","LU1037948897.HKD","GNOM","SG9999015945.SGD","SG9999015986.USD","BBH","GILD","MEDI","LU0289739699.SGD","BK4583","LU2089984988.USD","IBBQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782472","title":"BioNTech CEO Uğur Şahin Disposes of $6.48 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782472","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782472?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:30","pubTimestamp":1790800256,"startTime":"0","endTime":"0","summary":"BioNTech CEO Uur ahin disposes of $6.48 million in common sharesBioNTech CEO Ugur Sahin sold 66,000 ordinary shares on Sept. 29-30, 2026.Sales priced at USD 98.2591 and USD 98.1203 per share.Direct ho","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL955BQp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioNTech CEO Uğur Şahin Disposes of $6.48 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BNTX","BK4568","BK4139","BK4585","BK4588","BK4548","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782968","title":"Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782968","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782968?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:15","pubTimestamp":1790799300,"startTime":"0","endTime":"0","summary":"Moderna's eye-watering rally has officially outpaced its fundamentals, according to one analyst, prompting a downgrade at a major Wall Street firm.Citi's Geoff Meacham cut his rating on Moderna shares","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4551","BK4548","BK4585","IDNA","WDNA","MRNX","BK4532","BK4588","BK4534","GNOM","LGHT","BK4568","BK4533","BK4139","MRNA","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782978","title":"Corvus announces initiation of Phase 1b clinical trial of soquelitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782978","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782978?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:10","pubTimestamp":1790799031,"startTime":"0","endTime":"0","summary":"Corvus Pharmaceuticals (CRVS) announced that enrollment has begun in its Phase 1b clinical trial of soquelitinib for the treatment of patients with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/corvus-announces-initiation-of-phase-1b-clinical-trial-of-soquelitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/corvus-announces-initiation-of-phase-1b-clinical-trial-of-soquelitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVS","BK4139","NVIB","HYLG","BK4568","GDOC","MEDX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782367","title":"Corvus Starts Phase 1b Trial of Soquelitinib in Hidradenitis Suppurativa Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782367?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:06","pubTimestamp":1790798806,"startTime":"0","endTime":"0","summary":"Corvus starts Phase 1b trial of soquelitinib in hidradenitis suppurativa patientsCorvus Pharmaceuticals began enrolling a Phase 1b trial of soquelitinib in hidradenitis suppurativa, expanding developm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL1DBD0N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","BCDF","NDAQ","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4585","BK4139","IE00BQXX3F31.USD","SG9999014021.USD","LU2095319765.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BN0W2W23.USD","CRVS","LU0314104364.USD","LU2210149790.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","LU2210150020.SGD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672828167","title":"Corvus Pharmaceuticals, - Primary Endpoint is Safety and Tolerability; Key Efficacy Endpoint is Hiscr 50/75 at Week 12","url":"https://stock-news.laohu8.com/highlight/detail?id=2672828167","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672828167?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:05","pubTimestamp":1790798700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA7LJ4YH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","CRVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782812","title":"Corvus Pharmaceuticals Announces Initiation of Phase 1B Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782812","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782812?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:05","pubTimestamp":1790798700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA7LJ4YH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4568","CRVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672601784","title":"S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2672601784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672601784?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:30","pubTimestamp":1790796606,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeGen Digital Inc.GEN.OQ+6.9%Hewlett Packard Enterprise CompanyHPE.N+5.1%Synopsys, Inc.SNPS.OQ+4.9%CBOE Global Markets, Inc.CBOE.Z+4.3%Paramount Skydance CorpPSKY.OQ+3.8%Bottom PerformersPercent ChangeJabil Inc.JBL.N-10.2%Moderna, Inc.MRNA.OQ-5.9%Bloom Energy CorporationBE.N-4.8%AppLovin CorporationAPP.OQ-4.5%Constellation Energy CorpCEG.OQ-4.3%As of 03:30 p.m., the S&P 500.SPXgained 21.93 points, or 0.29%, to 7,692.77 and had posted 11 new 52-week highs and 21 new lows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL8N45M265:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","DBSC","LU0348723411.USD","SG9999018857.SGD","LU0957808578.USD","FUTY","BK4548","LU2211814178.USD","PSKY","LU1951200564.SGD","BK4613","LU1989764748.USD","SPYQ","BK4606","SGXZ99366536.SGD","LU1861214812.USD","LU2360107168.USD","SGXZ51526630.SGD","LU0321505868.SGD","LU1093756168.USD","ICLN","WDNA","LU2433249047.HKD","TSPY","MMAX","GSLC","IVV","CNRG","VEU","WLDR","IDU","LU1861215975.USD","BCDF","UPGR","LU1169589451.USD","VBK","ITOT","LU1303367103.USD","FRNW","SPYD","SPYG","SSO","SG9999004303.SGD","XDTE","JBL","APPC","IE00BD4GTT62.SGD","SFY","VTV","BEX","LU1064131342.USD","SPGP","ACWI","SG9999017495.SGD","BK4534","LU0225284248.USD","LU1821325948.USD","HYDR","BK4539","LGHT","BK4023","JXI","IE00B19Z3581.USD","IE00B894F039.SGD","LU1852331112.SGD","BEG","LU0444973449.USD","GNOM","IE00B19Z9P08.USD","LU1585245621.USD","LU1721428933.USD","LU2458330243.SGD","MRNY","LU2355687059.USD","LU2357125470.USD","IE00BZ199S13.USD","APPX","LU2543165471.USD","LU0353189763.USD","LU0006061336.USD","BK4501","SIMS","IVW","LU1814569148.SGD","BK4081","LU0957791311.USD","HIBS","ETFT","IBAT","LU0056508442.USD","SPHQ","IE00BD4GTW91.USD","BMAY","NOBL","LU2087625088.SGD","VPU","LU1923623000.USD","NLR","LU1923622614.USD","LU0390134368.USD","LU0306806265.USD","LU2506951792.HKD","IVE","BK4532","BK4009","SNPS","LU0096362180.USD","LU1861220033.SGD","SGXZ31699556.SGD","GPIX","LU0321505439.SGD","BK4512","IE00BFMHRM44.USD","SPUS","JEPI","MRNA","XYLD","MRNX","BEZ","LU0985481810.HKD","IE00B7SZLL34.SGD",".SPX","SG9999014898.SGD","LU0353189680.USD","LU1815333072.USD","VOO","TRUU","SH","SPYV","LU1642822529.SGD","APP","LU2125909759.SGD","LU0823414551.USD","LU1621768115.EUR","LU1854104046.USD","LU0109392836.USD","LU2290526834.HKD","LU1923622291.USD","LU1861219969.SGD","SPY","LU2264538146.SGD","MOAT","IJR","IE00BZ9MQY76.HKD","LU0082616367.USD","VTWG","LU2286300806.USD","LU2098885051.SGD","BK4515","IE0002270589.USD","LU2413666699.HKD","SCHX","CEGX","EGGY","LU1989764664.SGD","LU1571399168.USD","IE00B19Z3B42.SGD","LU2458330169.SGD","PRNT","LU1621767737.EUR","LU1621767810.EUR","IE00B19Z9Z06.USD","SGXZ81514606.USD","CEG","LU1815336760.USD","SPYH","VOOG","BK4608","VTI","IE0034235188.USD","HVAC","LU1988902786.USD","SCHB","LU0097036916.USD","BK4170","SPXS","BK4145","LU2294711713.HKD","BK4568","LU0823414478.USD","SG9999018865.SGD","SPUU","BK4533","LU0444971666.USD","BK4551","LU2413666426.HKD","SG9999014880.SGD","VCLN","BK4139","LU1169590202.USD","SPDN","XLG","WATS","XDAT","LU2063271972.USD","IE00BKPKM429.USD","LU0719512351.SGD","SPLV","SPXU","IVEP","BK4112","LU2360106780.USD","SPYM","DMAX","BK4125","CTEC","CBOE","SG9999014914.USD","SMAX","SPHD","SPMO","LU2250418816.HKD","BK4182","LU0154236417.USD","BK4543","LU0347712357.USD","RSPU","LU2125909247.SGD","BE","SDS","SG9999014906.USD","BEC","LU1093756325.SGD","SMOG","LU0306807586.USD","UPRO","LU0889565833.HKD","SPXL","JBLG","IE00BD4GTV84.USD","LU2247934214.USD","URAN","UTES","ALLW","HPEL","IJH","CLOD","LU1633808545.USD","LU2125909593.SGD","LU2125909916.SGD","LU1803068979.SGD","GEN","BK4588","SNPX","HIBL","XLU","ZAP","LU0476273544.USD","RSPA","LU1621768206.USD","SPYU","UPW","VV","LU1951198990.SGD","RSP","RSPN","BK4097","LU1430594728.SGD","YSPY","LU0061474960.USD","BK4541","BK4585","HPE","IE0009354923.USD","LU2360107325.USD","LU2384288077.EUR","LU2249611893.SGD","SGXZ23171101.USD","IDNA","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672784566","title":"Gilead put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2672784566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672784566?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:15","pubTimestamp":1790795714,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Gilead (GILD) with 6,354 puts trading, or 4x expected. Most active are Nov-26 140 puts and 10/9 weekly 146 puts, with total v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU0234570918.USD","LU1778281490.HKD","BK4532","BK4568","LU1057294990.SGD","LU1839511570.USD","LU2087621335.USD","LU0889565916.HKD","LU1585245621.USD","BMED","LU0965509010.AUD","LU0965509283.SGD","BK4583","LU2468319806.SGD","LU0058720904.USD","SG9999015945.SGD","TMED","LU1066051498.USD","IE00BSNM7G36.USD","BK4588","BBH","SG9999015986.USD","IBB","IE00BKVL7J92.USD","BIB","LU2112291526.USD","IBBQ","LU0289739699.SGD","LU1037948897.HKD","LU1934455863.HKD","LU0823416689.USD","TBXU","LU0882574055.USD","LU2324357040.USD","MEDI","BK4585","LU1430594728.SGD","LU2357627491.SGD","LU0859254822.USD","BK4578","SG9999015952.SGD","SG9999015978.USD","IE00B3T34201.USD","BK4550","GILD","LU1061106388.HKD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672860867","title":"BioNTech Steps Deeper Into Lung Cancer With New Dareon-Rosetta35 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672860867","media":"TIPRANKS","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672860867?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:31","pubTimestamp":1790785875,"startTime":"0","endTime":"0","summary":"Biontech Se Sponsored Adr ($BNTX) announced an update on their ongoing clinical study. The Dareon-Rosetta35 study tests new cancer drugs in people ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biontech-steps-deeper-into-lung-cancer-with-new-dareon-rosetta35-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biontech-steps-deeper-into-lung-cancer-with-new-dareon-rosetta35-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4548","BK4535","BNTX","BK4139","BK4585","BK4588","BK4568"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":3,"totalSize":229,"code":"91000000","status":"200"}]}}